                         SEQUENCE LISTING



<110>  Susavion Biosciences, Inc.

 

<120>  Compositions and Methods of Treating Cancer with Glycomimetic 

       Peptides



<130>  24667-045PCT



<150>  US 62/614,956

<151>  2018-01-08



<150>  US 62/699,345

<151>  2018-07-17



<160>  6     



<170>  PatentIn version 3.5



<210>  1

<211>  6

<212>  PRT

<213>  Artificial Sequence



<220>

<223>  Synthetic Sequence



<400>  1



Asn Gln His Thr Pro Arg 

1               5       





<210>  2

<211>  12

<212>  PRT

<213>  Artificial Sequence



<220>

<223>  Synthetic Sequence



<400>  2



Val Gln Ala Thr Gln Ser Asn Gln His Thr Pro Arg 

1               5                   10          





<210>  3

<211>  4

<212>  PRT

<213>  Artificial Sequence



<220>

<223>  Synthetic Sequence



<400>  3



Gly Gly Gly Ser 

1               





<210>  4

<211>  8

<212>  PRT

<213>  Artificial Sequence



<220>

<223>  Synthetic Sequence



<400>  4



Gly Gly Gly Ser Gly Gly Gly Ser 

1               5               





<210>  5

<211>  4

<212>  PRT

<213>  Artificial Sequence



<220>

<223>  Synthethic Sequence



<400>  5



Ser Ser Ser Ser 

1               





<210>  6

<211>  8

<212>  PRT

<213>  Artificial Sequence



<220>

<223>  Synthetic Sequence



<400>  6



Ser Ser Ser Ser Ser Ser Ser Ser 

1               5               





